Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potassium-Binding Agents for the Clinical Management of Hyperkalemia.

Literature DB >> 26765867

Potassium-Binding Agents for the Clinical Management of Hyperkalemia.

Martin Chaitman, Deepali Dixit, Mary Barna Bridgeman.

Abstract

Use of sodium polystyrene sulfonate (SPS) dominates the long-term treatment of hyperkalemia, but two new agents, sodium zirconium cyclosilicate and the recently FDA-approved patiromer, may offer potential advantages compared with SPS.

Entities: Chemical Disease

Keywords: hyperkalemia; patiromer; sodium polystyrene sulfonate; sodium zirconium cyclosilicate

Year: 2016 PMID： 26765867 PMCID： PMC4699486

Source DB: PubMed Journal: P T ISSN： 1052-1372

37 in total

1. Management of hyperkalemia with a cation-exchange resin.

Authors: L SCHERR; D A OGDEN; A W MEAD; N SPRITZ; A L RUBIN
Journal: N Engl J Med Date: 1961-01-19 Impact factor: 91.245

Review 2. Interventions for non-oliguric hyperkalaemia in preterm neonates.

Authors: Prakash Vemgal; Arne Ohlsson
Journal: Cochrane Database Syst Rev Date: 2012-05-16

3. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.

Authors: C G Acker; J P Johnson; P M Palevsky; A Greenberg
Journal: Arch Intern Med Date: 1998-04-27

Review 4. Relation of electrolyte disturbances to cardiac arrhythmias.

Authors: C Fisch
Journal: Circulation Date: 1973-02 Impact factor: 29.690

5. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.

Authors: A Blumberg; P Weidmann; P Ferrari
Journal: Kidney Int Date: 1992-02 Impact factor: 10.612

Review 6. Ototoxicity of loop diuretics.

Authors: L P Rybak
Journal: Otolaryngol Clin North Am Date: 1993-10 Impact factor: 3.346

7. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease.

Authors: C Gruy-Kapral; M Emmett; C A Santa Ana; J L Porter; J S Fordtran; K D Fine
Journal: J Am Soc Nephrol Date: 1998-10 Impact factor: 10.121

8. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.

Authors: I Meyer
Journal: ANNA J Date: 1993-02

9. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.

Authors: C E McGowan; S Saha; G Chu; M B Resnick; S F Moss
Journal: South Med J Date: 2009-05 Impact factor: 0.954

Review 10. Management of severe hyperkalemia.

Authors: Lawrence S Weisberg
Journal: Crit Care Med Date: 2008-12 Impact factor: 7.598

26 in total

1. How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders.

Authors: Mitja Lainscak
Journal: Card Fail Rev Date: 2017-04

Review 2. Progress in the Presence of Failure: Updates in Chronic Systolic Heart Failure Management.

Authors: Katie M Murphy; Julie L Rosenthal
Journal: Curr Treat Options Cardiovasc Med Date: 2017-07

3. The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers.

Authors: Kathryn Fitch; J Michael Woolley; Tyler Engel; Helen Blumen
Journal: Am Health Drug Benefits Date: 2017-06

Review 4. Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale.

Authors: David E St-Jules; Deborah J Clegg; Biff F Palmer; Juan-Jesus Carrero
Journal: Clin J Am Soc Nephrol Date: 2021-10-20 Impact factor: 8.237

Review 5. Incremental Hemodialysis: What We Know so Far.

Authors: Vivek Soi; Mark D Faber; Ritika Paul
Journal: Int J Nephrol Renovasc Dis Date: 2022-04-29

6. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.

Authors: Simon D Roger; Bruce S Spinowitz; Edgar V Lerma; Bhupinder Singh; David K Packham; Ayman Al-Shurbaji; Mikhail Kosiborod
Journal: Am J Nephrol Date: 2019-10-28 Impact factor: 3.754

7. Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study.

Authors: Shun Kohsaka; Suguru Okami; Eiichiro Kanda; Naoki Kashihara; Toshitaka Yajima
Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-01-19

8. Treatment of Mild Hyperkalemia in Hospitalized Patients: An Unnecessary Practice?

Authors: Tracy A Freeze; Leanne Skerry; Emily Kervin; Rosemary Nunn; Jennifer Woodland; Natasha Hanson; Martin MacKinnon
Journal: Can J Hosp Pharm Date: 2021-07-01

Review 9. Hyperkalaemia in Heart Failure.

Authors: Umar Ismail; Kiran Sidhu; Shelley Zieroth
Journal: Card Fail Rev Date: 2021-05-12

10. Effects of sodium zirconium cyclosilicate on sodium and potassium excretion in healthy adults: a Phase 1 study.

Authors: Mats Någård; Bhupinder Singh; David W Boulton
Journal: Clin Kidney J Date: 2020-12-13